Clinical and genetic study of 46 Italian patients with primary lymphedema

Lymphology

Volumn 45, Issue 1, 2012, Pages 3-12

  Michelini, Sandro ^a   Degiorgio, D ^b   Cestari, M ^a,c   Corda, D ^d   Ricci, M ^e   Cardone, M ^a,c   Mander, A ^f   Famoso, L ^c   Contini, E ^d   Serrani, R ^e   Pinelli, L ^b   Cecchin, S ^b   Bertelli, M ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b International Association of Medical Genetics (MAGI onlus)   (Italy)

^c Pianeta Linfedema Study Center   (Italy)

^d Polimedica San Lanfranco   (Italy)

^e Azienda Ospedali Riuniti di Ancona   (Italy)

^f Rehabilitative Centre Vaclav Vojta   (Italy)

Author keywords

Distichiasis; FLT4 alias VEGFR3; Forkhead domain; FOXC2; Genotype phenotype relationship; Primary lymphedema

Indexed keywords

FMS RELATED TYROSINE KINASE 4; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR FOXC2; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR 3;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; ITALY; LYMPHEDEMA; LYMPHEDEMA DISTICHIASIS; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIMARY LYMPHEDEMA; PRIORITY JOURNAL; PROTEIN DOMAIN; ADULT; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; LYMPHANGIOGENESIS; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE;

AGE OF ONSET; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LYMPHANGIOGENESIS; LYMPHEDEMA; MALE; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; YOUNG ADULT;

EID: 84864099825     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Connell, F, G Brice, P Mortimer: Phenotypic characterization of primary lymphedema. Ann. N. Y. Acad. Sci. 1131 (2008), 140-146. (Pubitemid 351758511)
2. Fang, J, LD Susan, RP Erickson, et al: Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67 (2000), 1382-1388.
3. Holberg, CJ, RP Erickson, MJ Bernas, et al: Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families. Am. J. Med. Genet. 98 (2001), 303-312. (Pubitemid 32126007)
4. Ferrell, RE, KL Levinson, JH Esman, et al: Hereditary lymphedema: Evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 7 (1998), 2073-2078. (Pubitemid 28546416)
5. Neufeld, G, T Cohen, S Gengrinovitch, et al: Vascular endothelial growth factor (VEGF) and its receptors. FASEB. J. 13 (1999), 9-22. (Pubitemid 29038270)
6. Bell, R, G Brice, AH Child, et al: Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum. Genet. 108 (2001), 546-551. (Pubitemid 32700358)
7. Szuba, A, M Skobe, MJ Karkkainen, et al: Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16 (2002), 1985-1987.
8. Kriederman BM, TL Myloyde, MH Witte, et al: FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol. Genet. 12 (2003), 1179-1185. (Pubitemid 36622150)
9. Finegold, DN, V Schacht, MA Kimak, et al: HGF and MET mutations in primary and secondary lymphedema. Lymphat. Res. Biol. 6 (2008), 65-68. (Pubitemid 351873446)
10. Ferrell, RE, MA Kimak, EC Lawrence, et al: Candidate gene analysis in primary lymphedema. Lymphat. Res. Biol. 6 (2008), 69-76. (Pubitemid 351873442)
11. Ferrell, RE, CJ Baty, MA Kimak, et al: GJC2 missense mutations cause human lymphedema. Am. J. Hum. Genet. 86 (2010), 943-948.
12. Irrthum, A, D Koenraad, D Chitayat et al: Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis- lymphedema- telangiectasia. Am. J. Hum. Genet. 72 (2003), 1470-1478. (Pubitemid 36628386)
13. Ostergaard, P, MA Simpson, FC Connell, et al: Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43 (2011), 929-931.
14. Alders, M, BM Hogan, E Gjini, et al: Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat. Genet. 41 (2009), 1272-1274.
15. Connell, FC, P Ostergaard, C Carver, et al: Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum. Genet. 124 (2009), 625-631.
16. Brice, G, AH Child, A Evans, et al: Milroy disease and the VEGFR-3 mutation phenotype. J. Med. Genet. 42 (2005), 98-102. (Pubitemid 40204362)
17. Mangion, J, N Rahman, S Mansour, et al: A gene for lymphedema- distichiasis maps to 16q24.3. Am. J. Hum. Genet. 65 (1999), 427-432. (Pubitemid 30463000)
18. Finegold, DN, MA Kimak, EC Lawrence, et al: Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet. 10 (2001), 1185-1189. (Pubitemid 32487541)
19. Brice, G, S Mansour, R Bell, et al: Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet. 39 (2002), 478-483. (Pubitemid 34787740)
20. Bahuau, M, C Houdayer, M Tredano, et al: FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palate. Clin. Genet. 62 (2002), 470-473. (Pubitemid 36372779)
21. Fabretto, A, A Shardlow, F Faletra, et al: A case of lymphedema- distichiasis syndrome carrying a new de novo frameshift FOXC2 mutation. Ophthalmic Genet. 31 (2010), 98-100.
22. Mellor, RH, G Brice, AW Stanton, et al: Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 115 (2007), 1912-1920. (Pubitemid 46598905)
23. van Steensel, MA, RJ Damstra, MV Heitink, et al: Novel missense mutations in the FOXC2 gene alter transcriptional activity. Hum. Mutat. 30 (2009), 1002-1009.
24. International Society of Lymphology: 2009 Consensus Document of the International Society of Lymphology: the diagnosis and treatment of peripheral lymphedema. Lymphology 42 (2009), 51-60.
25. Betts, MJ, RB Russell: Amino acid properties and consequences of substitutions. In: Bioinformatics for Geneticists. Barnes, MR, IC Gray (Eds.), Wiley, 2003.
26. Berry, FB, Y Tamimi, MV Carle, et al: The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis. Hum. Mol. Genet. 14 (2005), 2619-2627. (Pubitemid 41300636)
27. Evans, AL, R Bell, G Brice, et al: Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J. Med. Genet. 40 (2003), 697-703. (Pubitemid 37100704)
28. Ghalamkarpour, A, S Morlot, A Raas-Rothschild, et al: Hereditary lymphedema type I associated with VEGFR3 mutation: The first de novo case and atypical presentations. Clin. Genet. 70 (2006), 330-335. (Pubitemid 44323399)
29. Pajusola, K, O Aprelikova, J Korhonen, et al: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52 (1992), 5738-5743.
30. Sholto-Douglas-Vernon, C, R Bell, G Brice, et al: Lymphoedema- distichiasis and FOXC2: unreported mutations, de novo mutation estimate, families without coding mutations. Hum. Genet. 117 (2005), 238-242. (Pubitemid 43136800)
31. Spiegel, R, A Ghalamkarpour, E Daniel-Spiegel, et al: Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3. J. Hum. Genet. 51 (2006), 846-850.
32. Cheung, L, J Han, A Beilhack, et al: An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 20 (2006), 363-370. (Pubitemid 46089663)